2022 International HBV Meeting

Published on 25/11/2022

18-22 September, 2022
Paris, France.

ENYO Pharma sponsored and attent the 2022 International HBV Meeting on 18-22 September, 2022 organized by our collaborator Dr. David Durantel, Director of Research in Infectiology and team leader at the International Center for Research in Infectiology (CIRI-INSERM), Lyon, France.
https://www.hbvmeeting.org/

Read next in 'Events'

• The 2024 international workshop on Alport syndrome
• ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
• 6th CKD Summit – Chronic Kidney Disease Drug Development
• ASN Kidney Week
• Alport Connect 2023, the annual Alport syndrome patient and family meeting in US